Study of Healthy Aging and Physical function with Elamipretide (SHAPE)

We had reported health benefits from single dose Elamipretide injection in older adults.

The goal of this study is to establish the safety and tolerability of 4-weeks of daily subcutaneous injections in older adult and explore the potential benefits from skeletal muscle, cognitive function to biomarkers of aging. In addition, to serve as stepping stone toward larger scale clinical trials aimed at understanding how Elamipretide may help reduce key signs of aging.

The study includes: a screening/baseline phase (two onsite visits), an intervention period (4-week daily injection of study drug), a mid-intervention check-in phone call, a post-intervention phase (two onsite visits), and a follow-up phase that includes a phone call approximately two weeks after your final visit.

You will be reimbursed $400 for completing the study and transportation costs will be covered.

Participant Eligibility

We are seeking individuals 65-80 yr who are free of chronic disease and are able to attend 2 baseline visits, 4-week daily injection of study drug, and 2 post interventional visits at Fred Hutchinson Cancer Center.

Contact

Sophia Liu
(206) 543-0209